Kieuhoa Vo, MD, MAS

Title(s)Associate Professor, Pediatrics
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-476-3831
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Notre DameB.S., Biological Sciences2004
    Indiana University School of MedicineM.D.2008
    Nationwide Children's HospitalPediatric Residency2011
    University of California, San FranciscoM.A.S., Clinical Research2015
    University of California, San FranciscoPediatric Oncology/Hematology Fellowship2015

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Patterns of Locoregional Relapse after Radiotherapy for High-Risk Neuroblastoma: A Multi-Institutional Study. International Journal of Radiation Oncology • Biology • Physics. 2022 Nov 1; 114(3):e488. Liu LK, Shaaban SS, Lerman LB, Chen CJ, Bagatell BR, Dubois DS, Shusterman SS, Ioakeim-Ioannidou IM, Yock YT, Dusenbery DK, Vo VK, Huang HM, Friedmann FA, Diller DL, Marcus MK, MacDonald MS, Terezakis TS, Braunstein BS, Hill-Kayser HC, Haas-Kogan HD. .
      View in: Publisher Site   Mentions:
    2. Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J). Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):3009-3009. Vo VK, Sabnis SA, Williams WP, Roy-Chowdhuri RS, Patton PD, Coffey CB, Reid RJ, Piao PJ, Saguilig SL, Alonzo AT, Berg BS, Jaju JA, Fox FE, Hawkins HD, Mooney MM, Takebe TN, Tricoli TJ, Janeway JK, Seibel SN, Parsons PD. .
      View in: Publisher Site   Mentions:
    3. Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e22003-e22003. Vo VK, Matthay MK, Groshen GS, Chi CY, Granger GM, Park PJ, Marachelian MA, DuBois DS. .
      View in: Publisher Site   Mentions:
    4. Phase 1/2 study of elraglusib (9-ING-41), a small molecule selective glycogen synthase kinase-3 beta (GSK-3ß) inhibitor, alone or with irinotecan, temozolomide/irinotecan or cyclophosphamide/topotecan in pediatric patients with refractory malignancies: Interim results. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e22015-e22015. DeNardo DB, Foster FJ, Pinto PN, Saulnier Sholler SG, Vo VK, Desai DA, Sun SJ, Wagner WL, Macy MM, Mody MR, Oesterheld OJ, Cash CT, Bhuta BR, Barbieri BE, Pearson PA, Cavalcante CL, Giles GF, Lulla LR. .
      View in: Publisher Site   Mentions:
    5. Incorporating Radiomics into Machine Learning Models to Predict Outcomes of Neuroblastoma. J Digit Imaging. 2022 06; 35(3):605-612. Liu G, Poon M, Zapala MA, Temple WC, Vo KT, Matthay KK, Mitra D, Seo Y. PMID: 35237892; PMCID: PMC9156639.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2022 09; 69(9):e29616. Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK. PMID: 35188340; PMCID: PMC9329207.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. Mol Cancer Ther. 2021 10; 20(10):2016-2025. Shah AT, Azad TD, Breese MR, Chabon JJ, Hamilton EG, Straessler K, Kurtz DM, Leung SG, Spillinger A, Liu HY, Behroozfard IH, Wittber FM, Hazard FK, Cho SJ, Daldrup-Link HE, Vo KT, Rangaswami A, Pribnow A, Spunt SL, Lacayo NJ, Diehn M, Alizadeh AA, Sweet-Cordero EA. PMID: 34353895; PMCID: PMC9307079.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. J Clin Oncol. 2021 11 01; 39(31):3506-3514. DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. PMID: 34270348; PMCID: PMC8547934.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    9. Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma. Cancer Med. 2021 04; 10(7):2232-2241. Temple WC, Vo KT, Matthay KK, Balliu B, Coleman C, Michlitsch J, Phelps A, Behr S, Zapala MA. PMID: 33314708; PMCID: PMC7982630.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma. J Nucl Med. 2021 01; 62(1):43-47. Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y. PMID: 32414950; PMCID: PMC9364877.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    11. Precision Medicine in Pediatric Oncology. Surg Oncol Clin N Am. 2020 01; 29(1):63-72. Vo KT, Parsons DW, Seibel NL. PMID: 31757314; PMCID: PMC7819485.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biol Blood Marrow Transplant. 2019 10; 25(10):2031-2039. Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT. PMID: 31199983; PMCID: PMC9161973.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT. Med Phys. 2019 May; 46(5):2477-2486. Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK. PMID: 30761545; PMCID: PMC6510622.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30131550; PMCID: PMC6162271.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    15. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2017 Apr 04; 8(14):23851-23861. Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. PMID: 27793021; PMCID: PMC5410349.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    16. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 10; 66:144-52. Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK. PMID: 27573428; PMCID: PMC7523915.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    17. Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9. Vo KT, Matthay KK, DuBois SG. PMID: 27274393; PMCID: PMC4896001.
      View in: PubMed   Mentions: 4  
    18. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5. Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. PMID: 26891183.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 07 15; 22(14):3643-50. Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. PMID: 26861456; PMCID: PMC4947459.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    20. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45. Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG. PMID: 26709890; PMCID: PMC4777644.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    21. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 01; 32(28):3169-76. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. PMID: 25154816; PMCID: PMC4171360.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    22. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5. Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. PMID: 23005346.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Kieuhoa's Networks
    Concepts (112)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-880-g43f982f8 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California